Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
60%
Total
Publications
147
Total Open
Publications
88
Total
Citations
5.7K
Open Access
Percentage
60%
Total
Publications
147
Total Open
Publications
88
Total
Citations
5.7K
Breakdown
Publisher Open
12%
Both
33%
Other Platform Open
15%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
21
Hybrid 39%
26
No Guarantees 29%
19
Other Platform Open
Domain 89%
63
Institution 21%
15
Public 17%
12
Other Internet 8%
6
Preprint 6%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 62 |
Europe PMC | Domain | 54 |
Semantic Scholar | Public | 12 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 6 |
University of Oslo - Duo Research Archive | Institution | 3 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
bioRxiv | Preprint | 3 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |
Georg-August-Universität Göttingen - GoeScholar The Publication Server of the Georg-August-Universität Göttingen | Other Internet | 2 |